about
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryUS Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisMolecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilliMethodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaThe antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosisMycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients.Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay.Mycobacterium insubricum sp. nov.Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov.Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species.Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species.Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient.Draft Genome Sequences of Mycobacterium kansasii Clinical StrainsUtility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands.Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.Rapidly growing nontuberculous mycobacteria cultured from home tap and shower water.Microevolution of Mycobacterium tuberculosis in a tuberculosis patient.Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies.Mycobacterium iranicum sp. nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents.Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH₃) emitted by Pseudomonas aeruginosa."Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis.Urinary Tract Infection Caused by a Capnophilic Proteus mirabilis StrainValidation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.High-Level Pan-Azole-Resistant AspergillosisIdentification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations.Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Fails To Identify Nontuberculous Mycobacteria from Primary Cultures of Respiratory Samples.High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.Role of rpsA gene sequencing in diagnosis of pyrazinamide resistanceFirst case of Mycobacterium heckeshornense cavitary lung disease in the Latin America and Caribbean regionClofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.Comparative study of IS6110 restriction fragment length polymorphism and variable-number tandem-repeat typing of Mycobacterium tuberculosis isolates in the Netherlands, based on a 5-year nationwide survey.Photo quiz: Female with long-standing cough.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseMoxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.Mycobacterium xenopi clinical relevance and determinants, the NetherlandsDraft Genome Sequences of Mycobacterium kansasii Strains 1010001454, 1010001458, 1010001468, 1010001493, 1010001495, and 1010001469, Isolated from Environmental Sources.Clustering of tuberculosis cases based on variable-number tandem-repeat typing in relation to the population structure of Mycobacterium tuberculosis in the Netherlands.
P50
Q26775045-2CA1DD87-C062-4D71-9772-9FB4F2F1984DQ26775974-E735990A-980E-4D76-A75F-03133F9B7B3EQ28289912-0DBD3E09-112E-4B91-9356-E126DE0D5E6BQ28389409-94BF1180-A819-4ADB-8A91-D6DC1F7B4B49Q28475461-1EE59F7C-2D22-493B-A3E2-5632CC059F47Q33423774-4FFA2937-9080-42FB-BA39-04CF701B4ECCQ33437452-D0EC7AA8-9146-4B87-8B1B-9ABC8E7728E2Q33462560-3CD91BF0-E86F-4743-9867-2715D9DCF540Q33484623-FC9DCF5A-8642-4812-AFEA-34A78C8C0D2AQ33485720-1D17B848-4C8B-48B6-8145-17F586A3BAA0Q33635138-205FD530-53EC-4ACF-970C-AF46E807F299Q33679868-318F5B60-EC3E-470B-80AE-97C9EBAB9321Q33753594-476190A8-8734-4D3C-8643-49AF110E63C2Q33899908-908873B8-43BF-4F7C-B376-55B955F3AD26Q34046259-20CD6CE4-5706-4B88-9608-DA1FE4F9B0BCQ34108961-40A5CCC1-FD3D-4DB0-888F-308ADFF545C6Q34190462-BB64F3C8-D5B6-48F0-AFFD-A890B908E102Q34265268-9AED5EE5-07DB-4BFE-8AD4-C6F05F8C1A8FQ34291042-F1641D5C-C342-4920-9230-031EB7AF6A08Q35193496-FC07FF91-EF1C-49B8-AC84-B1E3C3FE40D9Q35551599-C693354A-ED8D-497D-8C2B-FA71764C5BB9Q35599048-5D4D692C-7175-4E67-9739-42D3B2BB9C08Q35607402-3E2F9D94-A4E6-412D-87B5-1A930621EC58Q35689060-AC331EE2-0FF9-4345-91EE-B9FA93D7C6C5Q35757617-7E0530E9-903B-4A57-9CBA-5751C9998FC5Q35908202-52B9EA12-A8D5-41EE-9952-9706EAA79576Q36009030-C75C118D-5961-4CE9-AFDD-2D06769D9769Q36251223-1F6FE431-8766-471F-B905-2F2AAFF6E008Q36396162-D4910AD0-5E16-47EE-B456-3387BE6B79E5Q36506283-34C05A37-854C-402C-97BB-F5965F57FA47Q36527450-13C410E6-6539-4712-967C-AE785E9C4561Q36571826-E4900573-1AEB-4E58-81D7-809AB529CF4EQ36644647-A1AF83B6-F9C8-477A-9C43-7EFC634D275CQ36884405-A69B02DA-8FDE-487D-AD01-C78FBE252973Q36884446-BBEC850E-60E9-4AA9-9A62-EA8513E40DA5Q36887811-B5938AEE-9508-49F7-8398-A52CC60EBDE9Q36933441-B6FB6442-7706-4AAD-BB16-FE6BF1A3D01CQ36944740-61D85C63-13CF-485A-A382-7490F2D61197Q36964747-AFB108B2-46C4-45C4-A611-D4B5D98A6ADBQ36971190-58A6DECC-EA07-451A-934E-955CCF2771AC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jakko van Ingen
@ast
Jakko van Ingen
@en
Jakko van Ingen
@es
Jakko van Ingen
@nl
Jakko van Ingen
@sl
type
label
Jakko van Ingen
@ast
Jakko van Ingen
@en
Jakko van Ingen
@es
Jakko van Ingen
@nl
Jakko van Ingen
@sl
prefLabel
Jakko van Ingen
@ast
Jakko van Ingen
@en
Jakko van Ingen
@es
Jakko van Ingen
@nl
Jakko van Ingen
@sl
P1006
P214
P1006
P1053
D-5526-2014
P106
P1153
23988232600
P21
P213
0000 0003 8848 9770
P214
P31
P3829
P496
0000-0002-0581-2003
P734
P7859
viaf-281669569